2 fantastic ASX growth shares to buy this month

ResMed Inc. (ASX:RMD) and this ASX growth share could be ones to buy in January. Here's why they are rated highly…

| More on:
A young boy sits on his dad's shoulders while both flex their muscles.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you looking to add a growth share or two to your portfolio this month? Then take a look at the two ASX shares listed below.

Here's why they could be growth shares to buy right now:

Kogan.com Ltd (ASX: KGN)

The first growth share to look at is this ecommerce company. It has been a very strong performer over the last 12 months thanks to the accelerating shift to online shopping. With shops shutting at the height of the pandemic and people being locked down, millions of consumers went online for their shopping. This gave Kogan's performance a major boost, leading to explosive growth in FY 2020.

Pleasingly, although life is getting back to normal, consumers are still flocking online for shopping. This has led to Kogan's strong growth continuing in FY 2021. For example, during the first four months of FY 2021, Kogan's sales were up 99.8% and its operating earnings were up 268.8% over the same period last year.

In addition to this, the company has acquired online retailer Mighty Ape for NZ$120 million and furniture retailer Matt Blatt for $4.4 million. These additions look set to give its second half performance a boost.

Canaccord Genuity is a fan of Kogan and has a buy rating and $25.00 price target on its shares.

ResMed Inc. (ASX: RMD)

Another growth share to look at is ResMed. Its is a medical device company with a focus on the fast-growing sleep treatment market.

ResMed also manufactures ventilators, which have been in high demand during the pandemic. In fact, demand has been so strong, it offset softness in the sleep treatment side of the business and underpinned a very strong result in FY 2020 and stellar growth in the first quarter of the new financial year.

While COVID is likely to stifle the growth of the sleep treatment business in the near term, as fewer people are diagnosed with sleep apnoea, it has been tipped to accelerate its growth once trading conditions improve.

Analysts at Morgans are positive on the company. This week the broker retained its add rating and $30.99 price target on ResMed's shares. While it acknowledges that it could be facing some headwinds, it believes its future remains bright thanks to its new product pipeline and growing digital business.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Kogan.com ltd. The Motley Fool Australia has recommended Kogan.com ltd and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

Concept image of a businessman riding a bull on an upwards arrow.
Growth Shares

3 ASX growth shares to buy before the next bull market

These shares could fare well in the next bull market. Here's what analysts are tipping as buys.

Read more »

Two university students in the library, one in a wheelchair, log in for the first time with the help of a lecturer.
Growth Shares

3 no-brainer ASX shares to buy with $200 right now

You don't need a brain to see that these shares could be top picks right now.

Read more »

A man with a wide, eager smile on his face holds up three fingers.
Growth Shares

3 ASX growth stocks worth buying with $7,000 in your portfolio today

These stocks are all historic market beaters.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Growth Shares

3 ASX 200 shares with huge growth potential in the next decade

Analysts think these growth shares could be in the buy zone in July.

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop.
Growth Shares

Where I'd invest $5,000 into ASX 300 growth shares

These stocks have excellent growth potential.

Read more »

a woman sits at a computer with a satisfied expression on her face in a white room with greenery outside her window.
Growth Shares

The ASX growth stock up 10% this year with more room to move

This broker believes there’s still more in the tank for this telecommunications company 

Read more »

A couple stares at the tv in shock, one holding the remote up ready to press.
Growth Shares

3 high-conviction ASX 200 stocks to buy and hold

Brokers think these shares are among the best to buy now.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Growth Shares

The smartest ASX growth stocks to buy with $3,000 right now

Analysts think these shares would be top picks for smart investors.

Read more »